Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

List of Figures

Figure 1: Migraine - Nurtec ODT and Ubrelvy patient's Therapy abandonment data

Figure 2: Migraine - Annual Sales of Triptans and Non-Triptans in the U.S

Figure 3: Global Acute Migraine Drugs Market Size, By Value, 2018-2021 (USD Billion)

Figure 4: Global Acute Migraine Drugs Market Size, By Value, 2022-2028 (USD Billion)

Figure 5: Global Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 6: Global Acute Migraine Drugs Market Size, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 7: Global Acute Migraine Drugs Market Absolute Opportunity, By Ergot Alkaloids, 2018-2028 (USD Billion)

Figure 8: Global Acute Migraine Drugs Market Size, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 9: Global Acute Migraine Drugs Market Absolute Opportunity, By Analgesics, 2018-2028 (USD Billion)

Figure 10: Global Acute Migraine Drugs Market Size, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 11: Global Acute Migraine Drugs Market Absolute Opportunity, By Triptans, 2018-2028 (USD Billion)

Figure 12: Global Acute Migraine Drugs Market Size, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 13: Global Acute Migraine Drugs Market Absolute Opportunity, By Other Drug Types, 2018-2028 (USD Billion)

Figure 14: Global Acute Migraine Drugs Market Size, By Intravenous, By Value, 2018H--2028F (USD Billion & CAGR)

Figure 15: Global Acute Migraine Drugs Market Absolute Opportunity, By Intravenous, 2018-2028 (USD Billion)

Figure 16: Global Acute Migraine Drugs Market Size, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 17: Global Acute Migraine Drugs Market Absolute Opportunity, By Oral, 2018-2028 (USD Billion)

Figure 18: Global Acute Migraine Drugs Market Size, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 19: Global Acute Migraine Drugs Market Absolute Opportunity, By Nasal, 2018-2028 (USD Billion)

Figure 20: Global Acute Migraine Drugs Market Size, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 21: Global Acute Migraine Drugs Market Absolute Opportunity, By Other Routes of Administration, 2018-2028 (USD Billion)

Figure 22: Global Acute Migraine Drugs Market Size, By Over The Counter, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 23: Global Acute Migraine Drugs Market Absolute Opportunity, By Over The Counter, 2018-2028 (USD Billion)

Figure 24: Global Acute Migraine Drugs Market Size, By Prescription, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 25: Global Acute Migraine Drugs Market Absolute Opportunity, By Prescription, 2018-2028 (USD Billion)

Figure 26: Americas Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 27: Americas Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 28: Americas Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 29: Americas Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 30: Americas Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 31: Americas Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 32: Americas Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 33: Americas Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 34: Americas Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 35: Americas Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 36: Americas Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 37: Americas Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 38: United States Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 39: United States Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 40: United States Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 41: United States Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 42: United States Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 43: Canada Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 44: Canada Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 45: Canada Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 46: Canada Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 47: Canada Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 48: Rest of Americas Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 49: Rest of Americas Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 50: Rest of Americas Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 51: Rest of Americas Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 52: Rest of Americas Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 53: Europe Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 54: Europe Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 55: Europe Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 56: Europe Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 57: Europe Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 58: Europe Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 59: Europe Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 60: Europe Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 61: Europe Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 62: Europe Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 63: Europe Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 64: Europe Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 65: Germany Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 66: Germany Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 67: Germany Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 68: Germany Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 69: Germany Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 70: United Kingdom Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 71: United Kingdom Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 72: United Kingdom Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 73: United Kingdom Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 74: United Kingdom Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 75: France Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 76: France Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 77: France Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 78: France Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 79: France Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 80: Italy Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 81: Italy Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 82: Italy Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 83: Italy Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 84: Italy Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 85: Spain Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 86: Spain Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 87: Spain Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 88: Spain Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 89: Spain Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 90: Rest of Europe Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 91: Rest of Europe Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 92: Rest of Europe Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 93: Rest of Europe Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 94: Rest of Europe Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 95: Asia Pacific Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 96: Asia Pacific Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 97: Asia Pacific Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 98: Asia Pacific Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 99: Asia Pacific Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 100: Asia Pacific Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 101: Asia Pacific Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 102: Asia Pacific Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 103: Asia Pacific Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 104: Asia Pacific Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 105: Asia Pacific Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 106: Asia Pacific Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 107: China Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 108: China Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 109: China Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 110: China Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 111: China Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 112: Japan Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 113: Japan Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 114: Japan Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 115: Japan Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 116: Japan Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 117: India Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 118: India Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 119: India Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 120: India Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 121: India Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 122: Rest of Asia Pacific Acute Migraine Drugs Market, By Value, 2018-2028 (USD Billion & CAGR)

Figure 123: Rest of Asia Pacific Acute Migraine Drugs Market Value, By Drug Type, 2021 (USD Billion)

Figure 124: Rest of Asia Pacific Acute Migraine Drugs Market Share, By Drug Type, By Value, 2021 (%)

Figure 125: Rest of Asia Pacific Acute Migraine Drugs Market Share, By Route of Administration, By Value, 2021 (%)

Figure 126: Rest of Asia Pacific Acute Migraine Drugs Market Share, By Availability, By Value, 2021 (%)

Figure 127: Middle East & Africa Acute Migraine Drugs Market Size, By Value, 2018H-2028F (USD Billion)

Figure 128: Middle East & Africa Acute Migraine Drugs Market Share, By Drug Type, 2021 (%)

Figure 129: Middle East & Africa Acute Migraine Drugs Market, By Ergot Alkaloids, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 130: Middle East & Africa Acute Migraine Drugs Market, By Analgesics, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 131: Middle East & Africa Acute Migraine Drugs Market, By Triptans, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 132: Middle East & Africa Acute Acute Migraine Drugs Market, By Other Drug Types, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 133: Middle East & Africa Acute Acute Migraine Drugs Market, By Intravenous, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 134: Middle East & Africa Acute Acute Migraine Drugs Market, By Oral, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 135: Middle East & Africa Acute Acute Migraine Drugs Market, By Nasal, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 136: Middle East & Africa Acute Acute Migraine Drugs Market, By Other Routes of Administration, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 137: Middle East & Africa Acute Acute Migraine Drugs Market, By Over The Counter Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 138: Middle East & Africa Acute Acute Migraine Drugs Market, By Prescription Availability, By Value, 2018H-2028F (USD Billion & CAGR)

Figure 139: Global Impact of Drivers and Restraints

Figure 140: Market Share of Prominent Companies of Acute Migraine Drugs, 2021 (%)

Figure 141: Eli Lilly and Company Revenues, 2019-2021 (USD Million)

Figure 142: Eli Lilly and Company Revenues Revenue , By Business Segments, 2021 (%)

Figure 143: Eli Lilly and Company Revenues Revenue , By Business Segments, 2021 (%)

Figure 144: GSK plc. Revenues, 2019-2021 (USD Million)

Figure 145: GSK plc. Revenue , By Business Segments, 2021 (%)

Figure 146: GSK plc. Revenue , By Geographical Segments, 2021 (%)

Figure 147: Bayer AG . Revenues, 2019-2021 (USD Million)

Figure 148: Bayer AG . Revenue , By Business Segments, 2021 (%)

Figure 149: Bayer AG . Revenue , By Geographical; Segments, 2021 (%)

Figure 150: J&J Revenues, 2019-2021 (USD Million)

Figure 151: J&J Revenue , By Business Segments, 2021 (%)

Figure 152: JJ&J Revenue , By Geographical Segments, 2021 (%)

Figure 153: Teva Pharmaceuticals Revenues, 2019-2021 (USD Million)

Figure 154: Teva Pharmaceuticals Revenue , By Geographical Segments, 2021 (%)

Figure 155: AbbVie Inc. Revenues, 2019-2021 (USD Million)

Figure 156: AbbVie Inc. Revenue , Product Sales by Product Segment, 2021 (%)

Figure 157: AbbVie Inc. Revenue , By Geographical Segments, 2021 (%)

Figure 158: Novartis Revenues, 2019-2021 (USD million)

Figure 159: Novartis Revenue , By Business Segments, 2021 (%)

Figure 160: Novartis Revenue , By Geographical Segments, 2021 (%)

Figure 161: Merck & Co., Inc. Revenues, 2019-2021 (USD Million)

Figure 162: Merck & Co., Inc. Revenue , By Geographic segment, 2021 (%)

Figure 163: Merck & Co., Inc. Revenue , By Business Segments, 2021 (%)

Figure 164: Pfizer Inc. Revenues, 2019-2021 (USD Million)

Figure 165: Pfizer Inc. Revenue , By Business Segments- By Products, 2021 (%)

Figure 166: Pfizer Inc. Revenue , By Geographic Segments, 2021 (%)

Figure 167: Boehringer Ingelheim Revenues, 2019-2021 (USD Million)

Figure 168: Boehringer Ingelheim Revenue , By Business Segments- By Products, 2021 (%)

Figure 169: Boehringer Ingelheim Revenue , By Geographical Segments, 2021 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Acute Migraine Drugs in Pipeline

Table A3: United States Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A4: United States Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A5: United States Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A6: United States Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A7: United States Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A8: United States Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A9: Canada Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A10: Canada Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A11: Canada Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A12: Canada Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A13: Canada Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A14: Canada Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A15: Rest of Americas Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A16: Rest of Americas Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A17: Rest of Americas Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A18: Rest of Americas Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A19: Rest of Americas Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A20: Rest of Americas Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A21: Germany Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A22: Germany Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A23: Germany Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A24: Germany Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A25: Germany Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A26: Germany Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A27: United Kingdom Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A28: United Kingdom Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A29: United Kingdom Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A30: United Kingdom Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A31: United Kingdom Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A32: United Kingdom Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A33: France Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A34: France Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A35: France Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A36: France Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A37: France Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A38: France Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A39: Italy Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A40: Italy Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A41: Italy Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A42: Italy Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A43: Italy Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A44: Italy Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A45: Spain Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A46: Spain Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A47: Spain Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A48: Spain Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A49: Spain Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A50: Spain Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A51: Rest of Europe Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A52: Rest of Europe Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A53: Rest of Europe Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A54: Rest of Europe Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A55: Rest of Europe Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A56: Rest of Europe Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A57: China Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A58: China Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A59: China Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A60: China Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A61: China Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A62: China Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A63: Japan Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A64: Japan Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A65: Japan Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A66: Japan Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A67: Japan Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A68: Japan Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A69: India Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A70: India Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A71: India Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A72: India Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A73: India Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A74: India Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A75: Rest of Asia Pacific Acute Migraine Drugs Market, By Drug Type, By Value, 2018-2021 (USD Billion)

Table A76: Rest of Asia Pacific Acute Migraine Drugs Market, By Drug Type, By Value, 2022-2028 (USD Billion)

Table A77: Rest of Asia Pacific Acute Migraine Drugs Market, By Route of Administration, By Value, 2018-2021 (USD Billion)

Table A78: Rest of Asia Pacific Acute Migraine Drugs Market, By Route of Administration, By Value, 2022-2028 (USD Billion)

Table A79: Rest of Asia Pacific Acute Migraine Drugs Market, By Availability, By Value, 2018-2021 (USD Billion)

Table A80: Rest of Asia Pacific Acute Migraine Drugs Market, By Availability, By Value, 2022-2028 (USD Billion)

Table A81: Eli Lilly and Company Financials, 2019-2021

Table A82: GSK plc. Financials, 2019-2021

Table A83: Bayer AG Financials, 2019-2021

Table A84: Johnson & Johnson Financials, 2019-2021

Table A85: Teva Pharmaceuticals Financials, 2019-2021

Table A86: AbbVie Inc. Financials, 2019-2021

Table A87: Novartis Financials, 2019-2021

Table A88: Merck & Co., Inc. Financials, 2019-2021

Table A89: Pfizer Inc. Financials, 2019-2021

Table A90: Boehringer Ingelheim Financials, 2019-2021